SANJEEVAN ATWAL-KHANNA: Open Payments
NPI 1437424447 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,816 in 42 payments from 10 companies in 2025. Trend: 2023 $1,559 · 2024 $745 · 2025 $1,816
Food & beverage: $1,816
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $349 |
| Teva Pharmaceuticals USA, Inc. | 4 | $269 |
| Alkermes, Inc. | 9 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $241 |
| Janssen Pharmaceuticals, Inc | 4 | $208 |
| Neurocrine BioSciences, Inc. | 2 | $148 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Lundbeck LLC | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| ABBVIE INC. | 2 | $51 |
Products named: COBENFY, UZEDY, ARISTADA, CAPLYTA, INVEGA SUSTENNA, INGREZZA, ABILIFY MAINTENA, FANAPT.
Industry payments across CA — which companies pay providers there.
